Process indicators definition

Process indicators means variables that characterize how
Sample 1Sample 2Sample 3
Process indicators has the meaning provided in paragraph 3(a) of Xxxxx XXX.
Sample 1Sample 2
Process indicators means variables that characterize how educational programs are delivered and generally are items over which schools have some control.
Sample 1

Examples of Process indicators in a sentence

  • Process indicators will relate to implementation outputs and deliverables.

  • Process indicators including subproject inputs, expenditures, staff deployment, etc.

  • These indicators and benchmarks are of three kinds: • Process indicators including project inputs, expenditures, staff deployment, etc.; • Output indicators indicating results in terms of numbers of affected people compensated and resettled, training held, credit disbursed, etc.; and • Impact indicators related to the longer-term effect of the project on people's lives.

  • Process indicators represent the change in the quality and quantity of access and coverage of the activities and services.

  • Process indicators describe the extent to which measures are taken in relation to the articles of the Convention.

  • These indicators and benchmarks are of three kinds:  Process indicators including project inputs, expenditures, staff deployment, etc.

  • These indicators and benchmarks are of three kinds: • Process indicators including project inputs, expenditures, staff deployment, etc.• Output indicators indicating results in terms of numbers of affected people compensated and resettled, training held, credit disbursed, etc and• Impact indicators related to the longer-term effect of the project on people's lives.

  • These indicators and benchmarks are of three kinds: ▪ Process indicators including subproject inputs, expenditures, staff deployment, etc.

  • Process indicators including project inputs, expenditures, staff deployment, etc.

  • These indicators and benchmarks are of three kinds: • Process indicators including subproject inputs, expenditures, staff deployment, etc.• Output indicators indicating results in terms of numbers of affected people compensated and resettled, training held, credit disbursed, etc and• Impact indicators related to the longer-term effect of the subproject on people's lives.

Related to Process indicators

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Monitoring Indicator means a measure of HSP performance that may be monitored against provincial results or provincial targets, but for which no Performance Target is set;

  • Performance Indicators means the indicators for Project monitoring and evaluation set forth in the Operational Manual.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Collaborative matter means a dispute, transaction, claim, problem, or issue for resolution, including a dispute, claim, or issue in a proceeding, that is described in a collaborative law participation agreement and arises under the family or domestic relations law of this state, including any of the following:

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Service Territory means the geographic area within which PG&E as a Utility Distribution Company is authorized and required to provide electric transmission and distribution service.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Direction-indicator lamp means the lamp used to indicate to other road-users that the driver intends to change direction to the right or to the left;

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Performance Indicator means a measure of HSP performance for which a Performance Target is set; technical specifications of specific Performance Indicators can be found in the MSAA Indicator Technical Specifications document;

  • HIV means human immunodeficiency virus.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Project Milestones means the project milestones set forth in Schedule-G;

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Third Party Components means software and interfaces, licensed by RIM from a third party for incorporation into a RIM software product, or for incorporation into firmware in the case of RIM hardware products, and distributed as an integral part of that RIM product under a RIM brand, but shall not include Third Party Software.

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Runtime Product means the version specific files and application program interfaces (APIs) specified in the RUNTIME.TXT file provided with SAP Crystal Reports 2008, SAP Crystal Reports for Eclipse 2.0, and SAP Crystal Reports for Visual Studio 2010.

  • Final Product means a product that is not used in producing other products and is built and intended for use outdoors, provided the final product has not deteriorated or has otherwise become a potential source of contaminants.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).